Elcatonin
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Elcatonin
- DrugBank Accession Number
- DB13742
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Elcatonin
- Elcatonina
Pharmacology
- Indication
Not Available
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:Accelerate your drug discovery research with our fully connected ADMET dataset- Contraindications & Blackbox Warnings
Contraindications & Blackbox WarningsWith our commercial data, access important information on dangerous risks, contraindications, and adverse effects.Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Reduce medical errorsand improve treatment outcomes with our comprehensive & structured data on drug adverse effects.Reduce medical errors & improve treatment outcomes with our adverse effects data- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcalabrutinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Acalabrutinib. Acebutolol The risk or severity of adverse effects can be increased when Acebutolol is combined with Elcatonin. Acetohexamide The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Elcatonin. Afatinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Afatinib. Aldesleukin The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin. Alectinib The therapeutic efficacy of Elcatonin can be decreased when used in combination with Alectinib. Alendronic acid The risk or severity of hypocalcemia can be increased when Elcatonin is combined with Alendronic acid. Aminosalicylic acid The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aminosalicylic acid. Amitriptyline The risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptyline. Amitriptylinoxide The risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptylinoxide. 
Improve patient outcomesBuild effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.Learn more - Food Interactions
- Not Available
Categories
- ATC Codes
- H05BA04 — Elcatonin
- Drug Categories
- Amino Acids, Peptides, and Proteins
- Anti-Parathyroid Agents
- Bone Density Conservation Agents
- Calcitonin Preparations
- Calcium Homeostasis
- Calcium-Regulating Hormones and Agents
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Nerve Tissue Proteins
- Neuropeptides
- Peptide Hormones
- Peptides
- Proteins
- Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
- Thyroid Products
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- W0CMS474JK
- CAS number
- 60731-46-6
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Elcatonin
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created on June 23, 2017 20:47 / Updated on February 21, 2021 18:54